Form 4: Hims & Hers CTO Granted Significant RSU Award
Insider Transaction Report
Hims & Hers Health, Inc. CTO Mohamed Elshenawy was granted 376,222 Restricted Stock Units, vesting over four years.
Summary
- Mohamed Elshenawy, the Chief Technology Officer (CTO) of Hims & Hers Health, Inc. (HIMS), was granted 376,222 Restricted Stock Units (RSUs).
- The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The RSUs are subject to a service-based vesting requirement over a 4-year period.
- Vesting will occur in substantially equal quarterly installments on March 15, June 15, September 15, and December 15.
- The first vesting date is scheduled for June 15, 2026.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices aimed at aligning management incentives with shareholder interests and retaining key talent.
Positives
- The grant of Restricted Stock Units aligns the CTO's long-term interests with those of the shareholders, incentivizing sustained performance and growth.
- This compensation structure serves as a retention mechanism for a key executive, ensuring continuity in leadership and strategic direction.
Future Outlook
The granted Restricted Stock Units will vest over a four-year period in quarterly installments, indicating a long-term incentive structure for the CTO and potential future share ownership.
Industry Context
StockSavvy.ai notes that RSU grants are a standard component of executive compensation packages in the digital health and technology sectors. This practice is designed to align executive incentives with long-term shareholder value creation and to retain key talent in competitive markets.
Comparison to Industry Standards
- StockSavvy.ai notes that the size of this RSU grant for a CTO at a company like Hims & Hers Health, Inc. is generally within the expected range for executive compensation packages in the digital health and technology sectors, aiming to incentivize long-term performance and retention.
Stakeholder Impact
- Shareholders: The RSU grant aligns the CTO's financial interests with long-term shareholder value, potentially leading to more focused strategic execution.
- Employees: This grant to a senior executive may signal stability in leadership and a commitment to long-term growth, which can positively influence employee morale and retention.
- Management: The CTO receives a significant equity stake, providing a strong incentive for continued service and performance.
Next Steps
- The RSUs will begin vesting on June 15, 2026, and continue quarterly over a four-year period.
Key Dates
| Date | Description |
|---|---|
| 03/11/2026 | Date of earliest transaction (grant date of Restricted Stock Units). |
| 03/13/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
| 06/15/2026 | First Company Quarterly Vesting Date for the granted RSUs. |
Keywords
Hims & Hers, HIMS, Restricted Stock Units, RSU, Executive Compensation, CTO, Insider Transaction, Stock Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.